Page 4 - Jesse Shefferman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jesse shefferman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jesse Shefferman Today - Breaking & Trending Today

Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic .
Protara TherapeuticsApril 23, 2021 GMT
NEW YORK, April 23, 2021 (GLOBE NEWSWIRE) Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced a path forward related to TARA-002 for the treatment of Lymphatic Malformations (LMs), which are rare malformations of the lymphatic vasculature for which there is no U.S. Food and Drug Administration (FDA)-approved treatment. Based on feedback from the FDA, the Company intends to complete confirmatory, large-scale, GMP manufacturing comparability in the second half of 2021 and subsequently initiate a clinical study in pediatric LM patients pending alignment with FDA on study design. ....

United States , Jesse Shefferman , Justine Omalley , Exchange Commission , Company Contact , Drug Administration , Protara Therapeutics Inc , Lymphatic Malformations , Chief Executive Officer , Rare Pediatric Disease , Private Securities Litigation Reform Act , United States Securities , ஒன்றுபட்டது மாநிலங்களில் , ஜஸ்டின் ஓமல்லேய் , பரிமாற்றம் தரகு , நிறுவனம் தொடர்பு , தலைமை நிர்வாகி அதிகாரி , ரேர் குழந்தை நோய் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , ஒன்றுபட்டது மாநிலங்களில் பத்திரங்கள் ,

Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic Malformations

Provided by
GlobeNewswire
Apr 23, 2021 11:00 AM UTC
NEW YORK, April 23, 2021 (GLOBE NEWSWIRE) Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced a path forward related to TARA-002 for the treatment of Lymphatic Malformations (LMs), which are rare malformations of the lymphatic vasculature for which there is no U.S. Food and Drug Administration (FDA)-approved treatment. Based on feedback from the FDA, the Company intends to complete confirmatory, large-scale, GMP manufacturing comparability in the second half of 2021 and subsequently initiate a clinical study in pediatric LM patients pending alignment with FDA on study design. ....

United States , Jesse Shefferman , Justine Omalley , Exchange Commission , Company Contact , Drug Administration , Protara Therapeutics Inc , Lymphatic Malformations , Chief Executive Officer , Rare Pediatric Disease , Private Securities Litigation Reform Act , United States Securities , ஒன்றுபட்டது மாநிலங்களில் , ஜஸ்டின் ஓமல்லேய் , பரிமாற்றம் தரகு , நிறுவனம் தொடர்பு , தலைமை நிர்வாகி அதிகாரி , ரேர் குழந்தை நோய் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , ஒன்றுபட்டது மாநிலங்களில் பத்திரங்கள் ,

Protara Therapeutics Announces Appointment of Martín Sebastian Olivo, M.D. as Chief Medical Officer

Protara Therapeutics Announces Appointment of Martín Sebastian Olivo, M.D. as Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Buenos Aires , Distrito Federal , El Salvador , Justine Omalleyprotara , Sebastian Olivo , Jesse Shefferman , School Of Medicine , Austral University In Buenos Aires , Company Contact , Eisai Inc , University Of Buenos Aires , Gilead Sciences Inc , Exchange Commission , Breast Cancer Clinical Development , Immunomedics Inc , Therapeutics Inc , International Project Team Leader , Protara Therapeutics Inc , Pharmacological Research , University Of Salvador , Chief Medical Officer , Vice President , Breast Cancer Clinical Development Lead , Gilead Sciences , Chief Executive Officer ,

Protara Therapeutics Announces Appointment of Martín Sebastian Olivo, M.D. as Chief Medical Officer

Protara Therapeutics Announces Appointment of Martín Sebastian Olivo, M.D. as Chief Medical Officer
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United States , Buenos Aires , Distrito Federal , El Salvador , Sebastian Olivo , Jesse Shefferman , Justine Omalley , School Of Medicine , Austral University In Buenos Aires , Company Contact , Eisai Inc , University Of Buenos Aires , Gilead Sciences Inc , Exchange Commission , Breast Cancer Clinical Development , Immunomedics Inc , Therapeutics Inc , International Project Team Leader , Protara Therapeutics Inc , Pharmacological Research , University Of Salvador , Chief Medical Officer , Vice President , Breast Cancer Clinical Development Lead , Gilead Sciences , Chief Executive Officer ,

Protara Therapeutics Announces Appointment of Cynthia Smith to Board of Directors

Protara Therapeutics Announces Appointment of Cynthia Smith to Board of Directors
February 02, 2021 08:00 ET
| Source:
Protara Therapeutics
Protara Therapeutics
New York, New York, UNITED STATES
NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced the appointment of Cynthia Smith to its Board of Directors. Ms. Smith brings to Protara over 20 years of diverse leadership experience within the healthcare industry, most recently serving as Chief Commercial Officer at ZS Pharma.
“It is with great excitement that we welcome Cynthia to our Board of Directors,” said Jesse Shefferman ....

United States , Cynthia Smith , Jesse Shefferman , Justine Omalley , Company Contact , White House Office Of Management , Merck Co , Eagleton Institute Of Politics At Rutgers University , Exchange Commission , Wharton School , University Of North Carolina At Chapel Hill , Therapeutics Inc , Dicerna Pharmaceuticals , Protara Therapeutics Inc , Development At Affymax Inc , Chief Commercial Officer , Chief Executive Officer , Vice President , Market Access , Commercial Development , Healthcare Policy Analyst , White House Office , Spero Therapeutics , North Carolina , Chapel Hill , Eagleton Institute ,